Northwestern Mutual Wealth Management Co. acquired a new stake in Ventas, Inc. (NYSE:VTR - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 43,220 shares of the real estate investment trust's stock, valued at approximately $3,838,000.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Evolve Private Wealth LLC acquired a new position in shares of Ventas during the 2nd quarter worth about $328,000. Varma Mutual Pension Insurance Co acquired a new stake in shares of Ventas in the 2nd quarter valued at approximately $13,921,000. Westpac Banking Corp bought a new position in Ventas during the 2nd quarter worth approximately $8,973,000. Korea Investment CORP bought a new position in Ventas during the 2nd quarter worth approximately $21,496,000. Finally, Ieq Capital LLC acquired a new position in Ventas during the second quarter valued at approximately $13,913,000. Institutional investors and hedge funds own 94.18% of the company's stock.
Ventas Price Performance
VTR stock opened at $93.47 on Tuesday. The stock has a 50-day moving average price of $91.56 and a two-hundred day moving average price of $87.26. Ventas, Inc. has a 1 year low of $66.38 and a 1 year high of $101.60. The stock has a market cap of $47.94 billion, a PE ratio of 173.09, a price-to-earnings-growth ratio of 2.15 and a beta of 0.69. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86.
Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.96 by $0.01. The company had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The company's quarterly revenue was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.87 earnings per share. Equities analysts forecast that Ventas, Inc. will post 3.89 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several brokerages have commented on VTR. Scotiabank lowered their target price on shares of Ventas from $95.00 to $88.00 and set a "sector perform" rating for the company in a research note on Thursday, June 18th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a $100.00 price target on shares of Ventas in a research report on Tuesday, June 16th. Wells Fargo & Company boosted their price target on shares of Ventas from $93.00 to $96.00 and gave the company an "overweight" rating in a report on Monday, June 1st. Raymond James Financial initiated coverage on shares of Ventas in a research report on Tuesday, June 16th. They issued an "outperform" rating and a $94.00 price objective for the company. Finally, UBS Group raised their price objective on Ventas from $85.00 to $93.00 and gave the stock a "neutral" rating in a research note on Monday, May 4th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Ventas presently has a consensus rating of "Moderate Buy" and an average target price of $98.00.
Check Out Our Latest Analysis on Ventas
Insiders Place Their Bets
In other news, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the transaction, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. 0.53% of the stock is currently owned by company insiders.
About Ventas
(
Free Report)
Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas' business model combines property ownership with active asset management and capital markets activity.
See Also
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.